Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Usua Oyarbide

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Clinical Investigation|February 18, 2025
Reduced EIF6 dosage attenuates TP53 activation in models of Shwachman-Diamond syndromeUsua Oyarbide, Valentino Bezzerri, Morgan Staton, et al.
International Journal of Molecular Sciences|April 14, 2026
Tissue-Specific Expression of the EWSR1::FLI1 Fusion Protein Identifies <i>col2a1a</i>-Positive Cells as a Source of Ewing Sarcoma-like Tumors in ZebrafishRebecca A Anderson, Xin Chen, Usua Oyarbide, et al.
JCI Insight|August 8, 2020
Loss of Sbds in zebrafish leads to neutropenia and pancreas and liver atrophyUsua Oyarbide, Arish N Shah, Wilmer Amaya-Mejia, et al.
Scientific Reports|July 2, 2025
Tafazzin-deficient zebrafish display mitochondrial dysfunction, neutropenia, and metabolic defects without myopathyUsua Oyarbide, Rebecca A Anderson, Igor Radzikh, et al.
Research Square|May 2, 2025
Tafazzin-Deficient Zebrafish Display Mitochondrial Dysfunction, Neutropenia, and Metabolic Defects Without MyopathyUsua Oyarbide, Rebecca A Anderson, Igor Radzikh, et al.
Pediatric Blood & Cancer|June 26, 2025
Transcriptomic Profiling of Relapsed Rhabdomyosarcoma: Pre- and Post-Treatment Tissue Analysis Reveals Molecular Characteristics of Treatment FailureAndrew Muskara, Prarthana B Parthasarathy, Usua Oyarbide, et al.
British Journal of Haematology|October 25, 2023
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cellsMarco Cipolli, Christian Boni, Marianna Penzo, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Clinical Investigation|February 18, 2025
Reduced EIF6 dosage attenuates TP53 activation in models of Shwachman-Diamond syndromeUsua Oyarbide, Valentino Bezzerri, Morgan Staton, et al.
International Journal of Molecular Sciences|April 14, 2026
Tissue-Specific Expression of the EWSR1::FLI1 Fusion Protein Identifies <i>col2a1a</i>-Positive Cells as a Source of Ewing Sarcoma-like Tumors in ZebrafishRebecca A Anderson, Xin Chen, Usua Oyarbide, et al.
JCI Insight|August 8, 2020
Loss of Sbds in zebrafish leads to neutropenia and pancreas and liver atrophyUsua Oyarbide, Arish N Shah, Wilmer Amaya-Mejia, et al.
Scientific Reports|July 2, 2025
Tafazzin-deficient zebrafish display mitochondrial dysfunction, neutropenia, and metabolic defects without myopathyUsua Oyarbide, Rebecca A Anderson, Igor Radzikh, et al.
Research Square|May 2, 2025
Tafazzin-Deficient Zebrafish Display Mitochondrial Dysfunction, Neutropenia, and Metabolic Defects Without MyopathyUsua Oyarbide, Rebecca A Anderson, Igor Radzikh, et al.
Pediatric Blood & Cancer|June 26, 2025
Transcriptomic Profiling of Relapsed Rhabdomyosarcoma: Pre- and Post-Treatment Tissue Analysis Reveals Molecular Characteristics of Treatment FailureAndrew Muskara, Prarthana B Parthasarathy, Usua Oyarbide, et al.
British Journal of Haematology|October 25, 2023
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cellsMarco Cipolli, Christian Boni, Marianna Penzo, et al.
Pageof 2